U.S. markets close in 2 hours 7 minutes
  • S&P 500

    4,173.20
    +60.70 (+1.48%)
     
  • Dow 30

    34,384.45
    +363.00 (+1.07%)
     
  • Nasdaq

    13,401.99
    +277.00 (+2.11%)
     
  • Russell 2000

    2,213.42
    +42.47 (+1.96%)
     
  • Crude Oil

    65.23
    +1.41 (+2.21%)
     
  • Gold

    1,838.30
    +14.30 (+0.78%)
     
  • Silver

    27.38
    +0.32 (+1.19%)
     
  • EUR/USD

    1.2139
    +0.0054 (+0.45%)
     
  • 10-Yr Bond

    1.6450
    -0.0230 (-1.38%)
     
  • GBP/USD

    1.4094
    +0.0042 (+0.30%)
     
  • USD/JPY

    109.4160
    -0.0180 (-0.02%)
     
  • BTC-USD

    50,656.31
    +2,366.93 (+4.90%)
     
  • CMC Crypto 200

    1,419.25
    +60.69 (+4.47%)
     
  • FTSE 100

    7,043.61
    +80.28 (+1.15%)
     
  • Nikkei 225

    28,084.47
    +636.46 (+2.32%)
     

Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the first quarter 2021 on Thursday, April 29, 2021, following the close of the market. The company will discuss these results in a conference call scheduled for 3 PM Pacific Time (6 PM Eastern Time) that day.

To listen, call 855-779-9068 within the U.S. or 631-485-4862 outside the U.S., passcode: 4692298. You may also listen to the conference call live via a webcast that is available on the "Investor Relations" section of our website under "Quarterly Results" at bio-rad.com. The webcast will be available for up to a year.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with approximately 7,800 employees worldwide. Bio-Rad had revenues exceeding $2.5 billion in 2020. Please visit bio-rad.com for further information.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210415005335/en/

Contacts

Investor Contact:
Bio-Rad Laboratories, Inc.
Ilan Daskal, Executive Vice President
& Chief Financial Officer
510-724-7000
ir@bio-rad.com

Media Contact:
Bio-Rad Laboratories, Inc.
Tina Cuccia, Manager, Corporate Communications
510-741-6063
tina_cuccia@bio-rad.com